- Home
- VYGR vs CDRO Comparison
VYGR vs CDRO Comparison
Compare VYGR & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- CDRO
- Stock Information
- Founded
- VYGR 2013
- CDRO 2014
- Country
- VYGR United States
- CDRO Luxembourg
- Employees
- VYGR N/A
- CDRO N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- CDRO Services-Misc. Amusement & Recreation
- Sector
- VYGR Health Care
- CDRO Consumer Discretionary
- Exchange
- VYGR Nasdaq
- CDRO Nasdaq
- Market Cap
- VYGR 342.5M
- CDRO 347.9M
- IPO Year
- VYGR 2015
- CDRO N/A
- Fundamental
- Price
- VYGR $5.75
- CDRO $7.25
- Analyst Decision
- VYGR Strong Buy
- CDRO Strong Buy
- Analyst Count
- VYGR 9
- CDRO 2
- Target Price
- VYGR $16.44
- CDRO $9.50
- AVG Volume (30 Days)
- VYGR 485.6K
- CDRO 64.2K
- Earning Date
- VYGR 11-12-2024
- CDRO 11-27-2024
- Dividend Yield
- VYGR N/A
- CDRO N/A
- EPS Growth
- VYGR N/A
- CDRO N/A
- EPS
- VYGR 0.47
- CDRO N/A
- Revenue
- VYGR $163,784,000.00
- CDRO $151,877,729.00
- Revenue This Year
- VYGR N/A
- CDRO $37.91
- Revenue Next Year
- VYGR N/A
- CDRO $33.26
- P/E Ratio
- VYGR $12.33
- CDRO N/A
- Revenue Growth
- VYGR 3.40
- CDRO 51.93
- 52 Week Low
- VYGR $5.19
- CDRO $2.90
- 52 Week High
- VYGR $11.72
- CDRO $8.76
- Technical
- Relative Strength Index (RSI)
- VYGR 41.30
- CDRO 42.38
- Support Level
- VYGR $6.08
- CDRO $6.85
- Resistance Level
- VYGR $6.55
- CDRO $7.53
- Average True Range (ATR)
- VYGR 0.35
- CDRO 0.28
- MACD
- VYGR -0.05
- CDRO -0.05
- Stochastic Oscillator
- VYGR 14.51
- CDRO 30.77
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Italy, Mexico, Colombia, Panama and in the City of Buenos Aires where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. If the user wins, it pays out the bet. If the user loses, it keeps the amount wagered.